Breaking
Thursday, July 23, 2026
Share

Areas with Risk of Dengue: CDC map, criteria, and global reach

Sophie Martin Market Analysis Editor
Reviewed by James Park Regulatory Affairs Editor
Dengue Vaccine drug — Areas with Risk of Dengue: CDC map, criteria, and global reach
Visual context for this story · not clinical evidence

Decision brief

Answer first · skim in under a minute

CDC says nearly half the world’s population lives in areas with dengue risk, spanning the Americas, Africa, the Middle East, Asia, and the Pacific Islands. This update explains the CDC risk classifications and the altitude factor that helps define exposure areas.

Areas with Risk of Dengue, per CDC mapping, cover nearly half the world’s population—about 4 billion people—across the Americas, Africa, the Middle East, Asia, and the Pacific Islands. Travel and endemic-risk framing drives vaccine, antiviral, and vector-control demand signals.

Contents10 sections

Key Takeaways

  • CDC: almost half the world’s population (~4 billion people) live in areas with dengue risk.
  • Yellow Book: dengue is endemic in >100 countries/destinations in the tropics and subtropics.
  • Estimates cited by CDC include ~390 million DENV infections and ~96 million symptomatic cases per year.
  • Travel notices list countries with higher-than-usual cases; absence from a notice list does not mean zero transmission risk.

What does CDC mean by areas with risk of dengue?

CDC’s Areas with Risk of Dengue page states that almost half of the world’s population—about 4 billion people—live in areas with a risk of dengue, and that anyone who lives in or travels to such an area is at risk for infection (CDC dengue risk areas).

Regional maps cover Africa, Europe and the Middle East, the Americas and Caribbean, and Asia and Oceania.

How wide is endemic dengue geographically?

CDC’s Yellow Book chapter reports dengue is endemic throughout the tropics and subtropics and occurs in more than 100 countries and destinations worldwide, including Puerto Rico, the U.S. Virgin Islands, and U.S.-affiliated Pacific Islands (CDC Yellow Book: Dengue).

The same chapter cites estimates of about 390 million DENV infections and 96 million symptomatic cases per year as burden continues to grow in Sub-Saharan Africa, Latin America, and Asia.

How should travelers use CDC notices?

CDC Travelers’ Health issues level notices when countries report higher-than-usual dengue or when CDC sees elevated cases among returning U.S. travelers (Global Dengue travel notice).

CDC emphasizes that not all countries with transmission appear on outbreak lists; prevention measures apply across risk areas.

What altitude factor is commonly cited?

CDC risk communication frequently notes that mosquitoes capable of spreading dengue typically live at lower elevations; travel guidance often references practical elevation thresholds around 6,500 feet when assessing exposure, alongside local case history.

Altitude alone does not eliminate risk if competent vectors and virus circulation are present.

What remains unproven?

Global infection estimates are modeled. CDC maps are risk frameworks for public-health and travel advice, not precise commercial forecasts of vaccine uptake in any single country-year.

Why Areas with Risk of Dengue matter for APAC medical affairs

For Asia-Pacific travel medicine and vaccine strategy, CDC dengue risk maps and Yellow Book chapters are the default U.S. public-health reference. Endemic transmission across tropical Asia means expatriate, traveler, and urban outbreak scenarios all sit inside the same 4-billion-person risk envelope.

Outbreak notices flag elevated activity but do not redefine the baseline endemic map. Teams should maintain dual monitoring: static risk-area maps plus dynamic case alerts from CDC Travelers’ Health and WHO situational updates.

Vector control, community water storage, and Aedes density remain co-determinants of force of infection. Pharmaceutical interventions sit alongside those environmental controls rather than replacing them.

Related NovaPharma coverage

Frequently Asked Questions

How many people live in areas with risk of dengue?

CDC estimates almost half the world’s population—about 4 billion people—live in areas with a risk of dengue.

Is dengue limited to one continent?

No. CDC describes dengue risk across the Americas, Africa, the Middle East, Asia, and the Pacific Islands, with endemicity in more than 100 countries and destinations.

Do travel notices list every dengue-endemic country?

No. CDC states that not all countries with dengue transmission appear on higher-than-usual case lists; travelers should still use prevention in all risk areas.

Primary Sources

  1. CDC: Areas with Risk of Dengue
  2. CDC Yellow Book: Dengue
  3. CDC Travelers’ Health: Global Dengue notice
  4. WHO dengue fact sheet

Regulatory catalyst tracker

Track PDUFA dates, approval milestones, and label updates for Dengue Vaccine.

  • Jul 12, 2026 — PDUFA target
  • Priority Review — designation
  • Oncology — therapeutic area
Unlock full calendar →
Sources & references 1 primary sources
  1. cdc.gov

Sources verified at publication. See our editorial policy and data sources.

This article follows our editorial standards. Report a correction via editorial contact.